Alpha 2.0
Login Register
» Articles » PMID: 32369285

A Trial of Lopinavir-Ritonavir in Covid-19

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2020 May 6
PMID 32369285
Citations 11
Authors
Alberto Carmona-Bayonas
Paula Jimenez-Fonseca
Eduardo Castanon
Affiliations
Soon will be listed here.
Citing Articles

Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort.

Paroczai D, Bikov A, Blidaru A, Bobu E, Lascu A, Mot C Front Cell Infect Microbiol. 2025; 14:1496176.

PMID: 39885967 PMC: 11779713. DOI: 10.3389/fcimb.2024.1496176.

Learning in times of stress: Lessons from COVID-19 that will last throughout this century.

Jimenez-Fonseca P, Salazar R, Valenti V, Carmona-Bayonas A, Agnelli G Eur J Intern Med. 2021; 96:1-4.

PMID: 34801401 PMC: 8585637. DOI: 10.1016/j.ejim.2021.11.002.

Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.

Moreira T, Matos K, De Paula G, Santana T, Da Mata R, Pansera F Front Immunol. 2021; 12:709861.

PMID: 34475873 PMC: 8406802. DOI: 10.3389/fimmu.2021.709861.

Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial.

Tan D, Chan A, Juni P, Tomlinson G, Daneman N, Walmsley S Trials. 2021; 22(1):224.

PMID: 33752741 PMC: 7982877. DOI: 10.1186/s13063-021-05134-7.

Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects.

Liu C, Lu C, Wong S, Lin L Front Immunol. 2021; 11:616595.

PMID: 33613542 PMC: 7892464. DOI: 10.3389/fimmu.2020.616595.